136 Views
Quality Improvement Project
Presentation Type: Virtual Poster
Session: Council on Quality Improvement and Patient Safety Program
Tania M. Caballero, MD, MHS
Assistant Professor
Johns Hopkins School of Medicine
Johns Hopkins School of Medicine
Baltimore, Maryland
Disclosure: No Financial Relationships Disclosed
Sara C. Keller, MD, MPH, MSH.P.
Assistant Professor
Johns Hopkins School of Medicine
Baltimore, Maryland
Disclosure: No Financial Relationships Disclosed
Pranita D. Tamma, MD
Associate Professor
Johns Hopkins School of Medicine
Baltimore, Maryland
Disclosure: No Financial Relationships Disclosed
Melissa A. Miller, BSN, MD, MS
Medical Officer
Division of Healthcare-Associated Infections, Center for Quality Improvement and Patient Safety, at the Agency for Healthcare Research and Quality (AHRQ)
Rockville, Maryland
Disclosure: No Financial Relationships Disclosed
Prashila Dullabh, MD
Vice President and Senior Fellow
NORC at University of Chicago
Bethesda, Maryland
Disclosure: No Financial Relationships Disclosed
Roy Ahn, ScM, ScD, MPH
Vice President
NORC at University of Chicago
Chicago, Illinois
Disclosure: No Financial Relationships Disclosed
Savyasachi V. Shah, BDS, MPH
Research Scientist in Healthcare Evaluation
NORC at University of Chicago
Chicago, Illinois
Disclosure: No Financial Relationships Disclosed
Yue Gao, MPH
Senior Research Scientist
NORC at University of Chicago
Chicago, Illinois
Disclosure: No Financial Relationships Disclosed
Kathleen Speck, MPH
Research Project Administrator
Johns Hopkins School of Medicine
Baltimore, Maryland
Disclosure: No Financial Relationships Disclosed
Sara E. Cosgrove, MD
Associate Hospital Epidemiologist; Professor of Medicine
Johns Hopkins School of Medicine
Baltimore, Maryland
Disclosure: Basilea (Products/Services: consulting fees for serving on the adjudication committee) (Consultant)
Jeffrey A. Linder, MD, MPH
Chief of General Internal Medicine and Geriatrics; Professor of Medicine
Northwestern University School of Medicine
Chicago, Illinois
Disclosure: Amgen (Stockholder/Ownership Interest (excluding diversified mutual funds))Biogen (Stockholder/Ownership Interest (excluding diversified mutual funds))Eli Lilly (Stockholder/Ownership Interest (excluding diversified mutual funds))